Clinical Trial

Effect of Arestin-Enhanced SRP on Periodontal and Glycemic Outcomes in Diabetics

Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
Periodontitis is a prevalent chronic inflammatory disease that exacerbates systemic inflammation and poses challenges for glycemic control in diabetic patients. While scaling and root planing (SRP) remains the cornerstone of periodontal therapy, adjunctive treatments such as Arestin (minocycline microspheres) have shown promise in enhancing clinical outcomes. This study aims to evaluate the impact of adding Arestin to SRP on periodontal pocket closure, glycemic control, and systemic inflammation in diabetic patients with periodontitis.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-11.
Status change: Not Yet Recruiting → Recruiting 2026-02-18
Trial Details
NCT Number NCT07298057
Lead Sponsor Case Western Reserve University
Collaborators: OraPharma
Conditions Periodontitis, Diabetes Mellitus Type 2
Enrollment 42 participants
Start Date 2026-02-06
Primary Completion 2027-06 (estimated)
Study Completion 2028-06 (estimated)
Updated on ClinicalTrials.gov 2026-02-19